BB&T Securities’s Exact Sciences EXAS Stock Holding History

BB&T Securities’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,990	Closed	-$707K	–	1645
2019 Q2	$707K	Buy	5,990 +803	+15%	+$80.9K	0.01%	953
2019 Q1	$449K	Buy	+5,187	New	+$442K	﹤0.01%	1127

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

BB&T Securities's EXAS Position: Q3 2019 in Review

BB&T Securities sold out of Exact Sciences (EXAS) in Q3 2019, closing a stake of 5,990 shares — an estimated $707K sold.

BB&T Securities first reported a position in EXAS in Q1 2019 and held it in 2 quarters. The position peaked at $707K in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

BB&T Securities reported no remaining Exact Sciences position as of Q3 2019 after selling out during the quarter.
BB&T Securities sold 5,990 Exact Sciences shares in Q3 2019, an estimated $707K.
BB&T Securities first reported a position in Exact Sciences in Q1 2019 and held it in 2 quarters.
BB&T Securities's Exact Sciences position peaked at $707K in Q2 2019.
475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.